Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Philippe Fauchet

Philippe Fauchet

vc
Capital ownerFund operatorEcosystem influencer

About

Philippe Fauchet is a Japan-focused venture partner at 4BIO Capital and a longtime pharmaceutical executive who previously led Sanofi and GlaxoSmithKline businesses in Japan before becoming Chairman of GSK K.K. After leaving GSK in 2019, he moved into venture and advisory work across advanced therapies, joining boards including Rezolute, LUCA Science, Noile-Immune Biotech, and JCR Pharmaceuticals. He is also active in the life-science ecosystem as an advisor, mentor, and former adjunct professor at the University of Tokyo.

Areas of interest

biotechadvanced therapiescell therapygene therapyRNA-based therapytargeted therapiesmicrobiomeregenerative medicinepharmaceutical business developmentJapan-Europe life science collaborationglobal health policy